Switch to dolutegravir (DTG) in treatment-experienced people living with HIV (PLH) may lead to excess weight gain in high income settings. There are limited data on weight changes following switch to DTG in rural low-income settings with lower prevalence of obesity.
We conducted a retrospective cohort study at eight rural HIV clinics in western Kenya to evaluate weight changes following switch to DTG. We included PLH ?25 years old who switched before 1/1/2020, were on ART for at least one year prior to switch, & had weight measured at switch & within 14 months pre & post-switch. Using pre-switch data & linear mixed models, we predicted the post-switch weight trajectory for each participant if they had not switched to DTG, adjusting for sex, age, pre-switch regimen, & time. We contrasted the observed vs. predicted post-switch weight change with inference via non-parametric bootstrap.
We included 2838 PLH who switched to DTG/TDF/3TC (median age 48 years, 50% female). Median ART duration at switch was 6.6 years (IQR 4.4-9.1). At switch, 11% were underweight (BMI <18.5 kg/m2), 69% normal weight (BMI 18.5-24.9 kg/m2), 16% overweight (BMI 25-29.9 kg/m2), & 4% obese (BMI ?30 kg/m2). Pre-switch, 99.8% were on an NNRTI (EFV/NVP); NRTIs were TDF/3TC (65%, n=1864), AZT/3TC (26%, n=731), or d4T/3TC (9%, n=260). Among those with a measured pre-switch viral load (n=743), 95% were suppressed (<200 copies/mL). Mean 12-month weight change was 0.8 kg pre-switch & 0.4 kg post-switch. Observed 12-month post-switch weight was 0.5 kg less than predicted (95%CI -0.9 to -0.1) based on pre-switch weight trajectory, and only 0.2 kg less than predicted (95% CI -0.7 to 0.4) among those on TDF pre and post-switch. Restricting to those on TDF throughout, observed 12-month weight was: more than predicted for underweight (2.9 kg, 95% CI 1.3 to 4.5); similar to predicted for women (0.6 kg, 95% CI -0.2 to 1.3), pre-switch suppressed (-0.8 kg, 95% CI -1.9 to 0.3), & normal weight (-0.1 kg, 95% CI -0.7 to 0.5); and less than predicted for men (-1.0 kg, 95% CI -1.6 to -0.3) & overweight/obese (-1.9 kg, 95% CI -3.2 to -0.6).
In contrast to reports of weight gain following switch to DTG in high-income settings, we observed slightly less weight increase than predicted based on pre-switch trajectory among ART-experienced adults in rural Kenya. When restricting to those on TDF pre and post-switch, switch from NNRTI to DTG was not associated with weight gain except in those underweight at switch.